Commission approves Illumina's plan to unwind its completed acquisition of GRAIL

 Here. 

Oral Argument Before the FTC: Illumina, Inc. and Grail, Inc.– December 13, 2022

 Video here. 

Commission adopts interim measures to prevent harm to competition following Illumina's early acquisition of GRAIL

 EC, here. 

The unintended consequences of Vestager’s tougher take on ‘killer acquisitions’

 Politico, here. 

The Commission adopts a Statement of Objections in view of adopting interim measures following Illumina's early acquisition of GRAIL

 EC, here. 

Commission starts investigation for possible breach of the standstill obligation in Illumina / GRAIL transaction

 EC, here. 

Illumina’s $7.1 billion play for cancer startup Grail faces global headwinds

 MLex Podcast, here.